A Phase 2, Multicenter, Double Blinded, Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of VX-809 Alone and in Combination with VX-770 in Subjects with Cystic Fibrosis, Homozygous o
Read time: 1 mins
Last updated:15th Oct 2010
To evaluate the safety and tolerability when VX-809 is administered alone and when VX-809 is coadministered with VX-770. To evaluate the effect of VX-809 administered alone and VX-809 coadministered with VX-770 on sweat chloride.
|Study start date||2010-10-15|